Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause

References

• Portman DJ, Gass ML. on behalf of the Vulvovaginal Atrophy Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the international society for the study of women’s sexual health and the North American menopause society. Climacteric 2014;17:557–63
   PubMed Web of Science ®Google Scholar
• Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American menopause society. Menopause 2013;20:888–902
   PubMed Web of Science ®Google Scholar
• Palacios S, Castelo-Branco C, Currie H, et al. Update on management of genitourinary syndrome of menopause: a practical guide. Maturitas 2015;82:307–12
   Web of Science ®Google Scholar
• Baber RJ, Panay N, Fenton A. the IMS Writing Group. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 2016;19:109–50
   PubMed Web of Science ®Google Scholar
• The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of the North American menopause society. Menopause 2017;24:728–53
   PubMed Web of Science ®Google Scholar
• Gaspar A, Addamo G, Brandi H. Vaginal fractional CO2 laser: a minimally invasive option for vaginal rejuvenation. Am J Cosmetic Surg 2011;28:156–62
   Google Scholar
• Salvatore S, Nappi RE, Zerbinati N, et al. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric 2014;17:363–9
   PubMed Web of Science ®Google Scholar
• Salvatore S, Nappi RE, Parma M, et al. Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy. Climacteric 2015;18:219–25
   PubMed Web of Science ®Google Scholar
• Pagano T, De Rosa P, Vallone R, et al. Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and/or hormonal therapy for breast cancer: a retrospective study. Menopause 2016;23:1108–13
   PubMed Web of Science ®Google Scholar
• Sokol ER, Karram MM. An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy. Menopause 2016;23:1102–7
   PubMed Web of Science ®Google Scholar
• Vizintin Z, Lukac M, Kazic M, Tettamanti M. Erbium laser in gynecology. Climacteric 2015;18(Suppl 1):4–8
   PubMed Web of Science ®Google Scholar
• Gaspar A. Comparison of new minimally invasive Er: YAG laser treatment and hormonal replacement therapy in the treatment of vaginal atrophy. Climacteric 2014;17(Suppl 1):P124 [Abstr]
   Google Scholar
• Gambacciani M, Levancini M. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause. Minerva Ginecol 2015;67:97–102
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Levancini M. Vaginal erbium laser: the second generation thermotherapy for the genitourinary syndrome of menopause (GSM) in breast cancer survivors. A preliminary report of a pilot study. Ital J Gynaecol Obstet 2015;27:9–11
   Google Scholar
• Gambacciani M, Levancini M, Cervigni M. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric 2015;18:757–63
   PubMed Web of Science ®Google Scholar
• Gaspar A, Brandi H, Gomez V, Luque D. Efficacy of erbium: YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Lasers Surg Med 2017;49:160–8
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Levancini M. Vaginal erbium laser as second generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors. Menopause 2017;24:316–19
   PubMed Web of Science ®Google Scholar
• Fistonic N, Fistonic I, Findri-Gustek S, Bilajac Turina I, Kristofic I, Franic D, Laser treatment for stress urinary incontinence (SUI) in women. Proceedings of the 44th International Continence Society (ICS) Congress, Rio de Janeiro, Brazil. 20–24 October 2014
   Google Scholar
• Lukanovic A, et al. Non-ablative Er: YAG laser therapy effect on SUI related quality of life and sexual function: a randomized controlled trial. Proceedings of the 44th International Continence Society (ICS) Congress, Rio de Janeiro, Brazil. 20–24 October 2014
   Google Scholar
• Gambacciani M, Torelli MG, Martella L, et al. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence. Climacteric 2015;18(Suppl 1):43–8
   PubMed Web of Science ®Google Scholar
• Fistonić N, Fistonić I, Guštek ŠF, et al. First assessment of short-term efficacy of Er: YAG laser treatment on stress urinary incontinence in women: prospective cohort study. Climacteric 2015;18(Suppl 1):37–42
   PubMed Web of Science ®Google Scholar
• Lee MS. Treatment of vaginal relaxation syndrome with an erbium: YAG laser using 90° and 360° scanning scopes: a pilot study & short-term results. Laser Ther 2014;23:129–38
   PubMedGoogle Scholar
• Ogrinc UB, Senčar S, Lenasi H. Novel minimally invasive laser treatment of urinary incontinence in women. Lasers Surg Med 2015;47:689–97
   PubMed Web of Science ®Google Scholar
• Fistonić N, Fistonić I, Guštek ŠF, et al. Minimally invasive, non-ablative Er: YAG laser treatment of stress urinary incontinence in women-a pilot study. Lasers Med Sci 2016;31:635–43
   PubMed Web of Science ®Google Scholar
• Pardo JI, Solà VR, Morales AA. Treatment of female stress urinary incontinence with Erbium-YAG laser in non-ablative mode. Eur J Obstet Gynecol Reprod Biol 2016; 204:1–4
   PubMed Web of Science ®Google Scholar
• Tien YW, Hsiao SM, Lee CN, Lin HH. Effects of laser procedure for female urodynamic stress incontinence on pad weight, urodynamics, and sexual function. Int Urogynecol J 2017;28:469–76
   PubMed Web of Science ®Google Scholar
• Lapii GA, Yakovleva AY, Neimark AI, Lushnikova EL. Structural reorganization of the vaginal mucosa in stress urinary incontinence under conditions of Er: YAG laser treatment. Bull Exp Biol Med 2017;162:510–14
   PubMed Web of Science ®Google Scholar
• Gaspar A, Brandi H. Non-ablative erbium YAG laser for the treatment of type III stress urinary incontinence (intrinsic sphincter deficiency). Lasers Med Sci 2017;32:685–91
   PubMed Web of Science ®Google Scholar
• Sencar S, Bizjak-Ogrinc U, Vizintin Z, Evaluation of Er: YAG laser treatment for higher-grade pelvic organ prolapses – 1-year follow-up. Proceedings of 20th World Congress on Controversies in Obstetrics, Gynaecology & Infertility (COGI), Paris, France, 4–7 December 2014
   Google Scholar
• Bizjak Ogrinc U, Sencar S, Non-surgical minimally invasive Er: YAG laser treatment for higher-grade cystocele. NDP 373, 38th Annual IUGA Meeting, Dublin, Ireland; May 28th–June 1st, 2013
   Google Scholar
• Gambacciani M, Palacios S. Laser therapy for the restoration of vaginal function. Maturitas 2017;99:10–15
   PubMed Web of Science ®Google Scholar
• Tadir Y, Gaspar A, Lev-Sagie A, et al. Light and energy based therapeutics for genitourinary syndrome of menopause: consensus and controversies. Lasers Surg Med 2017;49:137–59
   PubMed Web of Science ®Google Scholar
• Cervigni M, Gambacciani M. Female urinary stress incontinence. Climacteric 2015;18(Suppl 1):30–6
   PubMed Web of Science ®Google Scholar
• Keane DP, Sims TJ, Abrams P, Bailey AJ. Analysis of collagen status in premenopausal nulliparous women with genuine stress incontinence. Br J Obstet Gynaecol 1997;104:994–8
   PubMedGoogle Scholar
• Rechberger T, Postawski K, Jakowicki JA, et al. Role of fascial collagen in stress urinary incontinence. Am J Obstet Gynecol 1998;179:1511–14
   PubMed Web of Science ®Google Scholar